EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Metabolic Reprogramming in Retinoblastoma Patients: Treatment Naïve Active Retinoblastoma Versus Regressed Tumors Post-Treatment

Khushboo Gulati, Harshi Saxena, Radhika Manukonda, Shivani Malpotra, Manikyaprabhu Kairamkonda, Krishna Mohan Poluri, Swathi Kaliki

Investigative Ophthalmology & Visual Science · 2025

DOI: 10.1167/iovs.66.15.12 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2025. Verfasst von Khushboo Gulati und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Operation Eyesight Universal Institute for Eye Cancer, L. V. Prasad Eye Institute, Hyderabad-, Telangana, India. Hauptthemen laut MEDLINE: Retinoblastoma, Retinal Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RetinoblastomaRetinal NeoplasmsBiomarkers, TumorHumansMaleFemaleMetabolomicsChild, PreschoolInfantMetabolomeMagnetic Resonance SpectroscopyChildMetabolic Reprogramming

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • The Operation Eyesight Universal Institute for Eye Cancer, L. V. Prasad Eye Institute, Hyderabad-, Telangana, India.
  • Brien Holden Eye Research Center, L. V. Prasad Eye Institute, Hyderabad, Telangana, India.
  • Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, India.
  • Centre for Nanotechnology, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, India.

Zitieren

APA

Gulati, K., Saxena, H., Manukonda, R., Malpotra, S., Kairamkonda, M., Poluri, K. M., & Kaliki, S. (2025). Metabolic Reprogramming in Retinoblastoma Patients: Treatment Naïve Active Retinoblastoma Versus Regressed Tumors Post-Treatment. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.15.12

Vancouver

Gulati K, Saxena H, Manukonda R, Malpotra S, Kairamkonda M, Poluri KM, et al. Metabolic Reprogramming in Retinoblastoma Patients: Treatment Naïve Active Retinoblastoma Versus Regressed Tumors Post-Treatment. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.15.12

BibTeX
@article{Gulati2025,
  author = {Gulati, Khushboo and Saxena, Harshi and Manukonda, Radhika and Malpotra, Shivani and Kairamkonda, Manikyaprabhu and Poluri, Krishna Mohan and Kaliki, Swathi},
  title = {Metabolic Reprogramming in Retinoblastoma Patients: Treatment Naïve Active Retinoblastoma Versus Regressed Tumors Post-Treatment},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  doi = {10.1167/iovs.66.15.12}
}
Kostenlos starten →